Inhibition of the Epstein-Barr virus lytic cycle by protoapigenone

Journal of General Virology

Volumn 92, Issue 8, 2011, Pages 1760-1768

  Tung, Chao Ping ^a   Chang, Fang Rong ^b   Wu, Yang Chang ^c   Chuang, Da Wei ^c   Hunyadi, Attila ^c,d   Liu, Shih Tung ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d UNIVERSITY OF SZEGED   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

4 O METHYLPHORBOL 13 ACETATE 12 MYRISTATE; BUTYRIC ACID; FLAVONOID; IMMEDIATE EARLY PROTEIN BZLF1; LACTATE DEHYDROGENASE; MITOGEN ACTIVATED PROTEIN KINASE; PROTOAPIGENONE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR EA D; TRANSCRIPTION FACTOR GAL4; TRANSCRIPTION FACTOR RTA; TRANSCRIPTION FACTOR VCA; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; DRUG SYNTHESIS; ENZYME ASSAY; EPSTEIN BARR VIRUS; FERN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; THELYPTERIS TORRESIANA; TRANSACTIVATION; VIRUS INHIBITION;

CELL LINE; CYCLOHEXANONES; DOWN-REGULATION; EPSTEIN-BARR VIRUS INFECTIONS; FERNS; FLAVONES; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; PLANT EXTRACTS; VIRAL PROTEINS;

HUMAN HERPESVIRUS 4; MACROTHELYPTERIS TORRESIANA;

EID: 79960368595     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.031609-0     Document Type: Article

References (41)

1. Adamson, A. L., Darr, D., Holley-Guthrie, E., Johnson, R. A., Mauser, A., Swenson, J. & Kenney, S. (2000). Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 activate the ATF2 transcription factor by increasing the levels of phosphorylated p38 and c-Jun N-terminal kinases. J Virol 74, 1224-1233.
2. Chang, F. R., Wei, J. L., Teng, C. M. & Wu, Y. C. (1998a). Antiplatelet aggregation constituents from Annona purpurea. J Nat Prod 61, 1457-1461.
3. Chang, P. J., Chang, Y. S. & Liu, S. T. (1998b). Role of Rta in the translation of bicistronic BZLF1 of Epstein-Barr virus. J Virol 72, 5128-5136.
4. Chang, L. K., Wei, T. T., Chiu, Y. F., Tung, C. P., Chuang, J. Y., Hung, S. K., Li, C. & Liu, S. T. (2003). Inhibition of Epstein-Barr virus lytic cycle by (2)-epigallocatechin gallate. Biochem Biophys Res Commun 301, 1062-1068.
5. Chang, Y., Chang, S. S., Lee, H. H., Doong, S. L., Takada, K. & Tsai, C. H. (2004). Inhibition of the Epstein-Barr virus lytic cycle by Ztatargeted RNA interference. J Gen Virol 85, 1371-1379.
6. Chang, L. K., Chung, J. Y., Hong, Y. R., Ichimura, T., Nakao, M. & Liu, S. T. (2005). Activation of Sp1-mediated transcription by Rta of Epstein-Barr virus via an interaction with MCAF1. Nucleic Acids Res 33, 6528-6539.
7. Chang, H. L., Wu, Y. C., Su, J. H., Yeh, Y. T. & Yuan, S. S. (2008a). Protoapigenone, a novel flavonoid, induces apoptosis in human prostate cancer cells through activation of p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase 1/2. J Pharmacol Exp Ther 325, 841-849.
8. Chang, L. K., Liu, S. T., Kuo, C. W., Wang, W. H., Chuang, J. Y., Bianchi, E. & Hong, Y. R. (2008b). Enhancement of transactivation activity of Rta of Epstein-Barr virus by RanBPM. J Mol Biol 379, 231-242.
9. Chang, F. R., Hsieh, Y. C., Chang, Y. F., Lee, K. H., Wu, Y. C. & Chang, L. K. (2010a). Inhibition of the Epstein-Barr virus lytic cycle by moronic acid. Antiviral Res 85, 490-495.
10. Chang, L. K., Chuang, J. Y., Nakao, M. & Liu, S. T. (2010b). MCAF1 and synergistic activation of the transcription of Epstein-Barr virus lytic genes by Rta and Zta. Nucleic Acids Res 38, 4687-4700.
11. Chen, L. W., Chang, P. J., Delecluse, H. J. & Miller, G. (2005). Marked variation in response of consensus binding elements for the Rta protein of Epstein-Barr virus. J Virol 79, 9635-9650.
12. Chen, Y. H., Chang, F. R., Wu, C. C., Yen, M. H., Liaw, C. C., Huang, H. C., Kuo, Y. H. & Wu, Y. C. (2006). New cytotoxic 6-oxygenated 8,9-dihydrofurocoumarins, hedyotiscone A-C, from Hedyotis biflora. Planta Med 72, 75-78.
13. Chen, Y. L., Lan, Y. H., Hsieh, P. W., Wu, C. C., Chen, S. L., Yen, C. T., Chang, F. R., Hung, W. C. & Wu, Y. C. (2008). Bioactive cembrane diterpenoids of Anisomeles indica. J Nat Prod 71, 1207-1212.
14. Chen, W. Y., Hsieh, Y. A., Tsai, C. I., Kang, Y. F., Chang, F. R., Wu, Y. C. & Wu, C. C. (2010). Protoapigenone, a natural derivative of apigenin, induces mitogen-activated protein kinase-dependent apoptosis in human breast cancer cells associated with induction of oxidative stress and inhibition of glutathione S-transferase pi. Invest New Drugs (Epub ahead of print).
15. Chevallier-Greco, A., Manet, E., Chavrier, P., Mosnier, C., Daillie, J. & Sergeant, A. (1986). Both Epstein-Barr virus (EBV)-encoded transacting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter. EMBO J 5, 3243-3249.
16. Chiu, Y. F., Tung, C. P., Lee, Y. H., Wang, W. H., Li, C., Hung, J. Y., Wang, C. Y., Kawaguchi, Y. & Liu, S. T. (2007). A comprehensive library of mutations of Epstein Barr virus. J Gen Virol 88, 2463-2472.
17. Cox, M. A., Leahy, J. & Hardwick, J. M. (1990). An enhancer within the divergent promoter of Epstein-Barr virus responds synergistically to the R and Z transactivators. J Virol 64, 313-321.
18. Datta, A. K., Feighny, R. J. & Pagano, J. S. (1980). Induction of Epstein-Barr virus-associated DNA polymerase by 12-O-tetradecanoylphorbol-13-acetate. Purification and characterization. J Biol Chem 255, 5120-5125.
19. Feederle, R., Kost, M., Baumann, M., Janz, A., Drouet, E., Hammerschmidt, W. & Delecluse, H. J. (2000). The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators. EMBO J 19, 3080-3089.
20. Fenton, M. & Sinclair, A. J. (1999). Divergent requirements for the MAPK(ERK) signal transduction pathway during initial virus infection of quiescent primary B cells and disruption of Epstein-Barr virus latency by phorbol esters. J Virol 73, 8913-8916.
21. Flemington, E. & Speck, S. H. (1990). Autoregulation of Epstein-Barr virus putative lytic switch gene BZLF1. J Virol 64, 1227-1232.
22. Gao, X., Ikuta, K., Tajima, M. & Sairenji, T. (2001). 12-Otetradecanoylphorbol-13-acetate induces Epstein-Barr virus reactivation via NF-kB and AP-1 as regulated by protein kinase C and mitogen-activated protein kinase. Virology 286, 91-99.
23. Giot, J. F., Mikaelian, I., Buisson, M., Manet, E., Joab, I., Nicolas, J. C. & Sergeant, A. (1991). Transcriptional interference between the EBV transcription factors EB1 and R: both DNA-binding and activation domains of EB1 are required. Nucleic Acids Res 19, 1251-1258.
24. Henle, G. & Henle, W. (1970). Observations on childhood infections with the Epstein-Barr virus. J Infect Dis 121, 303-310.
25. Jones, J. F., Shurin, S., Abramowsky, C., Tubbs, R. R., Sciotto, C. G., Wahl, R., Sands, J., Gottman, D., Katz, B. Z. & Sklar, J. (1988). T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections. N Engl J Med 318, 733-741.
26. Lee, C. L., Chang, F. R., Hsieh, P. W., Chiang, M. Y., Wu, C. C., Huang, Z. Y., Lan, Y. H., Chen, M., Lee, K. H. & Yen, H.-F. (2008a). Cytotoxicent-abietane diterpenes from Gelonium aequoreum. Phytochemistry 69, 276-287.
27. Lee, Y. H., Chiu, Y. F., Wang, W. H., Chang, L. K. & Liu, S. T. (2008b). Activation of the ERK signal transduction pathway by Epstein-Barr virus immediate-early protein Rta. J Gen Virol 89, 2437-2446.
28. Lin, J. C. (2003). Mechanism of action of glycyrrhizic acid in inhibition of Epstein-Barr virus replication in vitro. Antiviral Res 59, 41-47.
29. Lin, A. S., Nakagawa-Goto, K., Chang, F. R., Yu, D., Morris-Natschke, S. L., Wu, C. C., Chen, S. L., Wu, Y. C. & Lee, K. H. (2007). First total synthesis of protoapigenone and its analogues as potent cytotoxic agents. J Med Chem 50, 3921-3927.
30. Lin, T. P., Chen, S. Y., Duh, P. D., Chang, L. K. & Liu, Y. N. (2008). Inhibition of the Epstein-Barr virus lytic cycle by andrographolide. Biol Pharm Bull 31, 2018-2023.
31. Luka, J., Kallin, B. & Klein, G. (1979). Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate. Virology 94, 228-231.
32. Miller, G., El-Guindy, A., Countryman, J., Ye, J. & Gradoville, L. (2007). Lytic cycle switches of oncogenic human gammaherpesviruses. Adv Cancer Res 97, 81-109.
33. Naranatt, P. P., Akula, S. M., Zien, C. A., Krishnan, H. H. & Chandran, B. (2003). Kaposi's sarcoma-associated herpesvirus induces the phosphatidylinositol 3-kinase-PKC-zeta-MEK-ERK signaling pathway in target cells early during infection: implications for infectivity. J Virol 77, 1524-1539.
34. Ryan, J. L., Fan, H., Glaser, S. L., Schichman, S. A., Raab-Traub, N. & Gulley, M. L. (2004). Epstein-Barr virus quantitation by real-time PCR targeting multiple gene segments: a novel approach to screen for the virus in paraffin-embedded tissue and plasma. J Mol Diagn 6, 378-385.
35. Schepers, A., Pich, D. & Hammerschmidt, W. (1996). Activation of oriLyt, the lytic origin of DNA replication of Epstein-Barr virus, by BZLF1. Virology 220, 367-376.
36. Wang, Y. & Prywes, R. (2000). Activation of the c-fos enhancer by the erk MAP kinase pathway through two sequence elements: the c-fos AP-1 and p62TCF sites. Oncogene 19, 1379-1385.
37. Wang, Y. C., Huang, J. M. & Montalvo, E. A. (1997). Characterization of proteins binding to the ZII element in the Epstein-Barr virus BZLF1 promoter: transactivation by ATF1. Virology 227, 323-330.
38. Weiss, L. M., Movahed, L. A., Warnke, R. A. & Sklar, J. (1989). Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N Engl J Med 320, 502-506.
39. Wolf, H., zur Hausen, H. & Becker, V. (1973). EB viral genomes in epithelial nasopharyngeal carcinoma cells. Nat New Biol 244, 245-247.
40. Yajima, T., Yagihashi, A., Kameshima, H., Furuya, D., Kobayashi, D., Hirata, K. & Watanabe, N. (2000). Establishment of quantitative reverse transcription-polymerase chain reaction assays for human telomerase-associated genes. Clin Chim Acta 290, 117-127.
41. Yiu, C. Y., Chen, S. Y., Chang, L. K., Chiu, Y. F. & Lin, T. P. (2010). Inhibitory effects of resveratrol on the Epstein-Barr virus lytic cycle. Molecules 15, 7115-7124.